Efficacy of Anakinra in the Management of Patients With COVID-19 Infection in Qatar: A Randomized Clinical Trial
Latest Information Update: 18 Aug 2022
At a glance
- Drugs Anakinra (Primary)
- Indications COVID 2019 infections; COVID-19 pneumonia; Cytokine release syndrome; Respiratory distress syndrome
- Focus Therapeutic Use
- 15 Aug 2022 Status changed from recruiting to completed.
- 03 Dec 2020 New trial record